Literature DB >> 18071986

Atypical meningiomas: WHO moved the goalposts?

S J Smith1, S Boddu, D C Macarthur.   

Abstract

The histological grading of meningiomas underwent substantial revision and standardization in a WHO review of 2000. Prior to this the histological definition of atypical and malignant meningiomas was less tightly defined. We conducted a retrospective analysis of all meningiomas operated on between 1993 and 2003 in our unit (n=565), to assess whether the WHO changes had altered the proportion of tumours diagnosed as atypical. The percentage of tumours graded WHO II (atypical meningiomas) has increased significantly since these changes were adopted (18.3-23.1%, p=0.0408). We also examined the epidemiology of meningioma, finding that previous irradiation is associated with atypical meningiomas (p=0.038) and surgeons find that complete excision is also more difficult with atypical tumours (p=0.010), reporting poorer Simpson grades intraoperatively before the tumour grade is known. The increase in atypical lesions caused by the grading changes may lead to a corresponding increase in the numbers of patients referred for radiotherapy/radiosurgery, and we examine the evidence base for this strategy and whether our experience is replicated in other units.

Entities:  

Mesh:

Year:  2007        PMID: 18071986     DOI: 10.1080/02688690701684246

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  11 in total

Review 1.  Opportunities for clinical research in meningioma.

Authors:  Michael A Vogelbaum; C Leland Rogers; Mark A Linskey; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-11       Impact factor: 4.130

Review 2.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

3.  Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.

Authors:  Stephanie E Combs; Lutz Edler; Iris Burkholder; Stefan Rieken; Daniel Habermehl; Oliver Jäkel; Thomas Haberer; Andreas Unterberg; Wolfgang Wick; Jürgen Debus; Renate Haselmann
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

4.  Chordoid meningioma: a retrospective series of seven consecutive cases.

Authors:  Emiliano Passacantilli; Gennaro Lapadula; Federico Caporlingua; Jacopo Lenzi; Manila Antonelli; Francesca Santoro; Antonio Santoro
Journal:  Neurol Sci       Date:  2013-04-18       Impact factor: 3.307

5.  Metastatic meningiomas: an unusual clinical and pathological diagnosis with highly variable outcome.

Authors:  Fabien Forest; Sid-Ali Berremila; Cezar Gyenes; Carole Ginguéné; Radwan Kassir; Abdulrazzaq Sulaiman; Basile Pasquier; Jack Porcheron; Michel Péoc'h
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

6.  Stereotactic radiosurgery as a salvage treatment option for atypical meningiomas previously submitted to surgical resection.

Authors:  Kita Sallabanda; Marcos A Dos Santos; Jose B P Salcedo; Jose A G Diaz; Felipe A Calvo; Jose Samblas; Hugo Marsiglia
Journal:  J Radiosurg SBRT       Date:  2011

7.  Intracranial Meningiomas, WHO Grade Il : Prognostic Implications of Clinicopathologic Features.

Authors:  Hyung-Sik Moon; Shin Jung; Woo-Youl Jang; Tae-Young Jung; Kyung-Sub Moon; In-Young Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-07-31

Review 8.  Mast cells in meningiomas and brain inflammation.

Authors:  Stavros Polyzoidis; Triantafyllia Koletsa; Smaro Panagiotidou; Keyoumars Ashkan; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

9.  An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas.

Authors:  Christian Fernandez; Martin K Nicholas; Herbert H Engelhard; Konstantin V Slavin; Matthew Koshy
Journal:  Adv Radiat Oncol       Date:  2016-03-10

10.  [Relevance of Simpson's grades in the resection of grade I meningiomas].

Authors:  Pablo Ajler; Sofía Beltrame; Daniela Massa; Julian Tramontano; Matteo Baccanelli; Claudio Yampolsky
Journal:  Surg Neurol Int       Date:  2017-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.